Continue reading this on our app for a better experience

Open in App
The Edge Singapore
Home News Deals, joint ventures & alliances
PremiumPREMIUM
Deals, joint ventures & alliances

Biolidics in partnership to expand into China cancer diagnostics market

PC Lee
PC Lee • 1 min read
Biolidics in partnership to expand into China cancer diagnostics market
SINGAPORE (June 25): Medical technology company Biolidics has entered into a partnership with Zhongshan TopGene Medical Laboratory Co to develop and commercialise laboratory-developed tests (LDTs) in the field of circulating tumour cells (CTCs) using Biol
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.
TAGS
Biolidics
circulating tumour cells (CTCs)
laboratory-developed tests (LDTs)
ClearCell FX1 System

Highlights

Will the Rising Sun keep rising?
Geopolitics

Will the Rising Sun keep rising?

September 21, 2023
Trending Now
OCBC becomes first bank in Singapore to offer cross-border payments for customers through Alipay+
Proposed rezoning of Marina Square could have 'significant upsides' to NAVs, says DBS
Brokers’ Digest: Hong Leong Asia, Lendlease REIT, Suntec REIT, Frencken, Venture
TSMC asks suppliers to delay chip delivery, says Reuters
Thomson Medical has 3 months to restore public float

Related News

Biolidics: Pushing the frontiers of medical tech
Biolidics to start production of ClearEpi NAB Test
Singapore company Biolidics in talks to distribute Covid-19 test kits: PhillipCapital
Get the latest news updates in your mailbox
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.